MAY 31, 2017 7:39 AM PDT

Too close for comfort - gut microbes and metabolic disease

WRITTEN BY: Kerry Evans

We all know that gut bacteria are great, right? Right. Well, they’re great as long as they keep their distance from our intestinal epithelial cells. New research shows that the closer bacteria get to gut epithelial cells in humans, the more likely people are to develop metabolic diseases.

 

New research links gut microbes, epithelial cells, and metabolic disease. Image: Collective Evolution

 

According to study author Andrew Gewirtz, “previous studies in mice have indicated that bacteria that are able to encroach upon the epithelium might be able to promote inflammation that drives metabolic diseases, and now we've shown that this is also a feature of metabolic disease in humans, specifically type 2 diabetics who are exhibiting microbiota encroachment."

 

They collected samples from patients at the Veterans Administration Hospital in Atlanta, Georgia, who were undergoing a routine colonoscopy. Colon biopsies were used to investigate the relationship between “microbiota-mucus-epithelial juxtaposition” and risk factors for metabolic disease. The study subjects were middle-aged, 86% were overweight, 45% were obese, and 33% had diabetes.

 

Although the standard preparation for a colonoscopy - consumption of polyethylene glycol - removes many intestinal bacteria, the researchers were able to use the remaining bacteria to calculate the average distance of the bacteria from the epithelium. In healthy subjects (those without diabetes and who were not obese) the gut bacteria were found in the outer layer of mucus. In obese people with diabetes, however, the bacteria were found in much closer proximity to the epithelial cell layer.

 

Interestingly, the microbiota-epithelial distance was inversely correlated with specific markers of metabolic syndrome, including body-mass index, fasting blood glucose level, and A1C. In subjects with type 2 diabetes, the microbiota-epithelial distance was reduced by nearly 3-fold! This decrease remained even if the obese subjects were removed from the analysis.

 

Next, the researchers were curious about whether there was a correlation between the presence of specific immune cells in the gut and the microbiota-epithelial distance. They found more B cells in subjects with diabetes, but there were no changes in the number of dendritic cells or macrophages (compared to people without diabetes). These findings suggest that a decrease in microbiota-epithelial distance may activate mucosal B cells.

 

According to the study authors, “we envision that defining the interrelationship between microbiota encroachment, B-cell responses, and metabolic disease may elucidate the pathophysiology of metabolic syndrome and perhaps eventuate in novel strategies to treat and/or prevent this condition.”

 

Source: Cellular and Molecular Gastroenterology and Hepatology, Science Daily

 

 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
AUG 05, 2021
Cell & Molecular Biology
Concrete-Loving Bacteria Might be Helpful to Us
AUG 05, 2021
Concrete-Loving Bacteria Might be Helpful to Us
Some bacteria love to live in inhospitable environments that might be excessively hot, dry, or under intense pressure, e ...
AUG 19, 2021
Coronavirus
COVID-19 Vaccines Seem Well-Tolerated by Pregnant Women
AUG 19, 2021
COVID-19 Vaccines Seem Well-Tolerated by Pregnant Women
Trials of COVID-19 vaccines made by Pfizer, Moderna, and Johnson & Johnson have suggested that the vaccines are safe for ...
SEP 01, 2021
Coronavirus
It Seems Not All COVID-19 Patients Develop Antibodies
SEP 01, 2021
It Seems Not All COVID-19 Patients Develop Antibodies
It's been generally assumed that people who get infected with SARS-COV-2 will develop antibodies to the virus, which cau ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
SEP 20, 2021
Microbiology
Antibiotics and Viruses Team Up to Kill Drug-Resistant Bugs
SEP 20, 2021
Antibiotics and Viruses Team Up to Kill Drug-Resistant Bugs
Before antibiotics became a common treatment for infections, researchers considered using viruses that infect bacteria, ...
OCT 01, 2021
Microbiology
Understanding How the Gut Microbiome is Affected by Temperature
OCT 01, 2021
Understanding How the Gut Microbiome is Affected by Temperature
The gut microbiome has become an area of intense research focus in recent years. Genomic tools have enabled scientists t ...
Loading Comments...